RHUMBLINE ADVISERS

Position in ICLR — Icon PLC

CIK 1115418 BOSTON, MA

Position in ICLR

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$589,398

+$196,113 QoQ

Shares Held

3,393

-4.5% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#232

of 422 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,243,802,437 across 31 Diagnostics & Research names. ICLR ranks #29 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	593,946	$297,780,766
2	DHR	Danaher Corp /De/	995,923	$189,703,413
3	ILMN	Illumina, Inc.	560,716	$98,590,694
4	IDXX	Idexx Laboratories Inc /De	169,208	$89,077,859
5	A	Agilent Technologies, Inc.	500,807	$66,522,193
6	IQV	Iqvia Holdings Inc.	332,138	$64,175,704
7	WAT	Waters Corp /De/	168,771	$63,295,875
8	DGX	Quest Diagnostics Inc	267,727	$56,744,737

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$589,398	3,393	-4.5%	Shares	Sole	2026-08-12
2026-03-31	$393,285	3,554	-19.9%	Shares	Sole	2026-05-12
2025-12-31	$808,327	4,436	+55.8%	Shares	Sole	2026-02-13
2025-09-30	$498,400	2,848	+641.7%	Shares	Sole	2025-11-06
2025-06-30	$55,852	384	-91.1%	Shares	Sole	2025-08-12
2025-03-31	$755,431	4,317	+2.3%	Shares	Sole	2025-05-29
2024-12-31	$885,395	4,222	+1.8%	Shares	Sole	2025-05-29
2024-09-30	$1,191,187	4,146	-54.3%	Shares	Sole	2024-11-12
2024-06-30	$2,846,934	9,082	-89.7%	Shares	Sole	2024-08-01
2024-03-31	$29,663,377	88,297	-10.8%	Shares	Sole	2024-05-09
2023-12-31	$28,005,247	98,934	+0.3%	Shares	Sole	2024-02-08
2023-09-30	$24,278,033	98,591	-1.2%	Shares	Sole	2023-11-09
2023-06-30	$24,975,464	99,822	+6732.4%	Shares	Sole	2023-08-08
2023-03-31	$312,054	1,461	—	Shares	Sole	2023-05-11
No filing history on record for this holder in this stock.